OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

BioMerieux/  FR0013280286  /

Cboe Europe DXE
3/24/2023  5:29:56 PM Chg. +0.29 Volume Bid5:30:00 PM Ask5:30:00 PM Market Capitalization Dividend Y. P/E Ratio
100.25EUR +0.29% 39,439
Turnover: 2.21 mill.		 -Bid Size: - -Ask Size: - 15.88 bill.EUR 0.62% 29.42
GlobeNewswire 10/19/2021 USDA Appoints New Members to Food Safety Advisory Committee
GlobeNewswire 10/5/2021 Quotient Limited Announces Appointment of Chief Commercial Officer
GlobeNewswire 10/4/2021 Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
GlobeNewswire 9/16/2021 Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH
GlobeNewswire 6/1/2021 Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Upd...
GlobeNewswire 3/10/2021 Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
GlobeNewswire 2/23/2021 Quotient Limited Announces Manuel Mendez as Chief Executive Officer
GlobeNewswire 2/4/2021 Berkeley Lights Announces CFO Transition and C-Level Additions
GlobeNewswire 1/4/2021 Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
GlobeNewswire 12/16/2020 MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors
GlobeNewswire 12/7/2020 Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
GlobeNewswire 9/29/2020 Synairgen plc - Interim results for the six months ended 30 June 2020
GlobeNewswire 9/17/2020 Victory Square Provides Corporate Update on the Strong Performance of Portfolio Companies
GlobeNewswire 7/15/2020 DNV3837 antibiotic candidate: the Phase II trial continues in the US
GlobeNewswire 6/15/2020 T2 Biosystems Announces Changes to Board of Directors
GlobeNewswire 5/4/2020 Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
GlobeNewswire 4/1/2020 Cancer Biomarker Sales to Reach US$ 27 Bn by 2025; Government Funding Pivotal in Accelerating Market...
GlobeNewswire 3/18/2020 Commercial launch of BIOME Oléoactif®, new cosmetic active co-developed by Deinove and Hallstar Fran...
GlobeNewswire 3/11/2020 DEINOVE passes the 2nd milestone of the AGIR program and receives €1.5m from Bpifrance
GlobeNewswire 2/19/2020 DEINOVE expands its range of cosmetic active ingredients
GlobeNewswire 2/6/2020 Sharon Laboratories capitalizes on Deinove to sustain its development activities
GlobeNewswire 1/27/2020 Enrolment of first patient in Phase II trial testing DNV3837 in Clostridioides difficile infections
GlobeNewswire 1/22/2020 New industrial-scale production of Phyt-N-Resist® to supply the market
GlobeNewswire 12/9/2019 DEINOVE and ESPCI Paris obtain funding from the ANR to develop the Deinodrop technology
GlobeNewswire 12/6/2019 Evolution in DEINOVE's governance